{"id":"brn01","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Diarrhea"},{"rate":"20-40%","effect":"Nausea"},{"rate":"10-30%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"BRN01 works by inhibiting the CDK4/6 enzymes, which are involved in cell cycle progression. This inhibition leads to a decrease in cell proliferation and an increase in cell death, making it a potential therapeutic agent for various cancers.","oneSentence":"BRN01 is a small molecule targeting the CDK4/6 pathway.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:42:12.364Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breast cancer, HR-positive, HER2-negative"}]},"trialDetails":[{"nctId":"NCT01246427","phase":"PHASE3","title":"Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer","status":"COMPLETED","sponsor":"Centre Leon Berard","startDate":"2010-01","conditions":"Breast Cancer","enrollment":138}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"BRN01","genericName":"BRN01","companyName":"Centre Leon Berard","companyId":"centre-leon-berard","modality":"Small molecule","firstApprovalDate":"","aiSummary":"BRN01 is a small molecule targeting the CDK4/6 pathway. Used for Breast cancer, HR-positive, HER2-negative.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}